New diabetes clinical trial: A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Published on: October 30, 2023 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: Orforglipron; Drug: Placebo
Sponsors: Eli Lilly and Company
Not yet recruiting
https://ift.tt/Ks65ZkR